Record Operating Income and EBITDA
Achieved record operating income for the fourth consecutive quarter and second consecutive year, with EBITDA surpassing $400 million.
Strong Margins and Profitability
Delivered an operating margin of 15% in 2024, a target originally set for the end of 2025, with full-year earnings per share increasing by 18%.
Successful Shareholder Returns
Completed a $75 million share buyback program, increased dividends by 10%, and authorized a new $200 million share repurchase program.
Growth in Consumer-Oriented Markets
Consumer and Specialties segment saw a 25% growth in operating income, driven by innovations and expansion in pet care and specialty additives.
Innovative Product Developments
Launched new products, including pet litter with health indicators and sustainable additives, contributing to 18% of revenue from new products.